CIK 0001875558
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Nuvectis Pharma, Inc.
Sign in to watch- Ticker
- NVCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 862405608
- Phone
- +1 360-837-7232
- Business address
- 1 BRIDGE PLAZA, SUITE 275, FORT LEE, NJ, 07024
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Science & Business Off acquired 60,000 shares (grant or award)
- 4 Grant or award Chief Dev. & Ops. Officer acquired 60,000 shares (grant or award)
- 4 Grant or award Chairman & CEO acquired 120,000 shares (grant or award)
- 4 Open-market buy Chairman & CEO bought 4,000 shares at $7.05 ($28,200)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chairman & CEO bought 7,000 shares at $7.63 ($53,410)
- 4 Open-market buy Chairman & CEO bought 8,000 shares at $5.88 ($47,040)
- 4 Open-market buy Chairman & CEO bought 8,500 shares at $6.34 ($53,890)
- 4 Open-market buy Chief Science & Business Off bought 4,600 shares at an average $3.44 ($15,834)
- 4 Open-market buy Chief Development Officer bought 2,946 shares at an average $3.41 ($10,034)
- 4 Open-market buy Chairman & CEO bought 232,500 shares at an average $4.96 ($1,153,145)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 7 of 7 · 139 filings